Glucosamine use and risk of first-ever optic neuritis: A nationwide 16-year longitudinal analysis
Neuroepidemiology · 19.12.2024 · 1-23
DOI: 10.1159/000543184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroepidemiology, online erschienen am 19.12.2024. Verfasst von Yung-Yu Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei City, Taiwan. Hauptthemen laut MEDLINE: Glucosamine, Optic Neuritis. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Evidence of neuroprotective effects of glucosamine on Asian optic neuritis (ON) patients remains sparse. We aimed to examine the longitudinal association between glucosamine use and the incidence of first-ever ON to identify the factors contributing to reducing ON risk in older Asian populations.
Methods
This nationwide cohort study from 2000 to 2015 evaluated 24,155 individuals. The International Classification of Diseases-9-Clinical Modification code 377 determined newly diagnosed ON. Outcomes include the annual trend of first-ever ON incidence, crude/adjusted hazard ratios (HRs) of incident ON stratified by sociodemographic characteristics and comorbidities.
Results
Glucosamine exposure has been significantly associated with reduced ON incidence (Log-rank p < 0.001) since the fifth year of clinical surveillance. The overall adjusted HR of ON among glucosamine users was 0.718 (CI = 0.524–0.901, p = 0.001), and in the glucosamine-exposed group, disease onset was approximately 129 days later than in non-users (6.83 ± 4.27 vs. 6.47 ± 4.01 years to ON, p < 0.001). Moreover, glucosamine was associated with reduced ON risk in patients without diabetes mellitus, hypertension, tobacco use and chronic heart failure. While administering glucosamine, the risk was reduced by more than half among individuals aged between 45 and 64 years (aHR = 0.433, CI = 0.316–0.544, p < 0.001) and patients from medical centers (aHR = 0.453, CI = 0.330–0.568, p < 0.001).
Conclusion
Taiwanese glucosamine users have a decreased risk of developing ON. Our work provides a theoretical basis for expanding glucosamine indications in regions with minimal prevalence of ON.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei City, Taiwan.
- Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, Taipei City, Taiwan.
- Graduate Institute of Life Sciences, National Defense Medical Center, Taipei City, Taiwan.
- School of Public Health, National Defense Medical Center, Taipei City, Taiwan.
- Taiwanese Injury Prevention and Safety Promotion Association, Taipei City, Taiwan.
- Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei City, Taiwan, yj12664@gmail.com.
Zitieren
APA
Yang, Y. Y., Chien, W. C., Chung, C. H., Weng, T. H., & Chen, Y. J. (2024). Glucosamine use and risk of first-ever optic neuritis: A nationwide 16-year longitudinal analysis. Neuroepidemiology, 1-23. https://doi.org/10.1159/000543184
Vancouver
Yang YY, Chien WC, Chung CH, Weng TH, Chen YJ. Glucosamine use and risk of first-ever optic neuritis: A nationwide 16-year longitudinal analysis. Neuroepidemiology. 2024:1-23. doi:10.1159/000543184
BibTeX
@article{Yang2024,
author = {Yang, Yung-Yu and Chien, Wu-Chien and Chung, Chi-Hsiang and Weng, Tsu-Hsuan and Chen, Ying-Jen},
title = {Glucosamine use and risk of first-ever optic neuritis: A nationwide 16-year longitudinal analysis},
journal = {Neuroepidemiology},
year = {2024},
pages = {1--23},
doi = {10.1159/000543184}
}
EUVIMED